Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19-Associated Severe Acute Respiratory Distress Syndrome
- PMID: 35110028
- PMCID: PMC9472685
- DOI: 10.5152/TJAR.2020.1135
Thrombotic Events Related to Extracorporeal Membrane Oxygenation in COVID-19-Associated Severe Acute Respiratory Distress Syndrome
Abstract
Hypercoagulopathy associated with the novel coronavirus disease (COVID-19) is the leading cause of acute respiratory distress syndrome (ARDS), multiple organ failure, and mortality. Extracorporeal membrane oxygenation (ECMO) has been used to manage patients with COVID 19-associated severe respiratory or cardiac failure. In this report, we aim to summarise our experience with deadly thrombotic complications during venovenous ECMO (vvECMO) treatment in 6 patients with COVID-19-associated ARDS between March 19, 2020 and April 20, 2020. Based on our experience with 6 COVID-19-associated ARDS patients on ECMO, we intend to raise awareness regarding thrombotic complications leading to mortality.
Figures
References
-
- Frantzeskaki F, Armaganidis A, Orfanos SE. Immuno thrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation. Respiration. 2017;93:212-225. - PubMed
-
- Ogino Mark T. Extracorporeal Life Support Organization COVID-19 Interim Guidelines. ELSO. Accessed April, 16 2020. https://www.elso.org.
-
- Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. WHO. Accessed February 20, 2020. https://www.who.int/publications/i/item/10665-332299
LinkOut - more resources
Full Text Sources
Miscellaneous